-=6 HEADLINES

Indian Market

Indian equity markets were down 0.08%

Nifty up by 4.45 pts and settle at 5854.75

Sensex up by 14.68 pts at 19331.69

Bank Nifty down by 58.50 pts at 12042.00

Global Market

European markets were up with FTSE up by 32.00 closed at 6367 ,CAC up by 26.84 closed at 3733 and DAX up by 103.69 closed at 7765.

Dow future was up 25.00 closed at

14006.00

WWW.EPICRESEARCH.CO 09752199966

DAILY EQUITY NEWSLETTER

26TH FEBRUARY 2013

HEADLINES

• Coal India sure of NTPC signing FSA;

warns of price hike

• SBI fixes issue price at Rs 2312 for

preferential allotment

• Mid-cap, smallcap stocks crash;

regulators begin probe

• Ranbaxy up on restart of Atorvastatin

production in the US

FII’s and DII’s

CATEGORY DATE BUY SELL NET

FII 25-Feb-13 2527.79 2281.08 246.71

DII 25-Feb-13 820.75 982.72 -161.97

NIFTY DAILY PIVOTS

PIVOT R4 R3 R2 R1 PP S1 S2 S3 S4

NIFTY 6011 5958 5905 5879 5852 5826 5799 5746 5693

WWW.EPICRESEARCH.CO 09752199966

MARKET ANALYSIS:

Key benchmark indices eked out small gains in choppy trade on the first day of a crucial week. The

barometer index, the S&P BSE Sensex, advanced 14.68 points or 0.08%, off about 80 points from the

day's high and up close to 95 points from the day's low. Index heavyweight and cigarette major ITC

settled flat after witnessing intraday volatility. Index heavyweight Reliance Industries (RIL) dropped.

S&P BSE Sensex was up 14.68 points or 0.08% at 19,331.69, its highest closing level since 20 February

2013.

CNX Nifty was up 4.45 points or 0.08% at 5,854.75, its highest closing level since 20 February 2013..

Among the 30-share Sensex pack, 15 stocks gained while the rest of them declined

Cairn India rose 0.31%. The company said after market hours today, 25 February 2013, that following

endorsement of the exploration Work Programme for the Rajasthan Block (RJ-ON-90/1) by the

Management Committee less than two weeks ago, Cairn India has today, 25 February 2013,

commenced drilling of the first exploration well, after a gap of more than four years, in the prolific

Barmer Basin. Among other FMCG stocks, Tata Global Beverages, Dabur India, Godrej Consumer

Products and Hindustan Unilever dropped by 0.89% to 3.76%.GlaxoSmithkline Consumer Healthcare

was up 0.53%. The company announced during trading hours today, 25 February 2013, that Life

Insurance Corporation of India has sold 16.71 lakh equity shares of the company at Rs 3,900 per share.

STOCKS TO WATCH

ADANI ENTERPRISE

AUROBINDO PHARMA

AMBUJA

ITC

SCRIPS IN BAN PERIOD

IFCI

PUNJLYOD

SUZLON

RENUKA

WELCORP

WWW.EPICRESEARCH.CO 09752199966

.

EXPERT OPINION

NIFTY

Nifty looks Consolidate

Strategy: Sell on rise

Support: 5800

Resistance: 5900

BANK NIFTY

Bank Nifty looks Consolidate

Strategy: Sell on rise

Support: 11970

Resistance: 12110

460

.0

GAINERS AND LOOSERS

PREVIOUS PERFORMANCE

TYPE SCRIP B/S RESULT

CASH ANDHRA

BANK S TARGET HIT

CASH BHARTI AIRTEL

B TARGET HIT

FUTURE AUROBINDO

PHARMA S TARGET HIT

FUTURE AMBUJA B TARGET HIT

UPCOMING RESULTS

BATA INDIA

RANBAXY

DAILY NIFTY GAINERS

SCRIPS RATE VOL.

(000)

PR.

CLOSE

NET

CHAN

GE

%

CHANG

E

Ranbaxy Labs.

433.85 1836.44 413.55 20.30 4.91

Power Grid

Corpn. 112.05 8990.45 109.05 3.00 2.75

Infosys 2917.80 1307.15 2840.55 77.25 2.72

Tata Motors

299.15 5915.78 292.90 6.25 2.13

HCL Tech.

733.55 856.83 720.25 13.30 1.85

DAILY NIFTY LOOSERS

SCRIPS RATE VOL.

(000)

PR.

CLOSE

NET

CHAN

GE

%

CHAN

GE

DLF 271.65 9267.08 281.45 -9.80 -3.48

JP Associate

68.00 23374.96 70.25 -2.25 -3.20

Cipla 370.40 1479.98 380.70 -10.30 -2.71

Larsen & Toubro

1401.85 1204.00 1435.30 -33.45 -2.33

ONGC 317.90 3292.71 323.90 -6.00 -1.85

.

MARKET CALLS

CASH

SCRIPS ACTION LEVEL 1ST

TARGET 2ND

TARGET STOP LOSS

AUROBINDO PHARMA

SELL 172.80 171.80 170.80 173.80

JAIPRAKASH ASSOCIATE

SELL 67.50 67.00 66.25 68.00

FUTURE

SCRIPS ACTION LEVEL 1ST

TARGET 2ND

TARGET STOP LOSS

ADANI SELL 222.00 221.00 219.50 223.00

AMBUJA BUY 201.00 202.00 203.50 200.00

Disclaimer

The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most.

Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable.

This material is for personal information and based upon it & takes no responsibility

The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of NSE and BSE.

The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of the information is the acceptance of this disclaimer.

All Rights Reserved. Investment in equity & bullion market has its own risks.

We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken.